Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Severe Aplastic Anemia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT07586735
What this trial is testing

A Novel Conditioning Regimen for Haplo-HSCT in Older Patients With SAA

Who this might be right for
Severe Aplastic AnemiaAplastic AnaemiaHematopoietic Cell Transplant
Peking University People's Hospital 64
Large-scale testing (Phase 3)UnknownNCT03295058
What this trial is testing

Peripheral Blood Allogenic Stem Cell Transplantation Using Non-anti Thymocyte Globulin Regimens in Severe Aplastic Anemia Patients

Who this might be right for
Severe Aplastic Anemia
Assiut University 50
Testing effectiveness (Phase 2)UnknownNCT06254287
What this trial is testing

Efficacy and Safety of Avatrombopag vs. Avatrombopag Combined With rhTPO in the Treatment of SAA

Who this might be right for
Anemia, Aplastic
Institute of Hematology & Blood Diseases Hospital, China 60
Testing effectiveness (Phase 2)Study completedNCT03513328
What this trial is testing

Conditioning Regimen for Allogeneic Hematopoietic Stem-Cell Transplantation

Who this might be right for
Bone Marrow Failure SyndromeThalassemiaSickle Cell Disease+13 more
University of Florida 6
Testing effectiveness (Phase 2)Looking for participantsNCT04099966
What this trial is testing

AlloSCT for Malignant and Non-malignant Hematologic Diseases Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion

Who this might be right for
Acute LeukemiaSevere Aplastic AnemiaNon-hodgkin Lymphoma+6 more
Mitchell Cairo 20
Testing effectiveness (Phase 2)UnknownNCT02247973
What this trial is testing

Mesenchymal Stem Cells Co-transplantation in Alternative Donor Transplantation of Severe Aplastic Anemia.

Who this might be right for
Severe Aplastic Anemia
Guangzhou General Hospital of Guangzhou Military Command 100
Large-scale testing (Phase 3)Ended earlyNCT01163942
What this trial is testing

Randomized Study In Severe Aplastic Anemia Patients Receiving Atg, Cyclosporin A, With Or Without G-CSF (SAA-G-CSF)

Who this might be right for
Aplastic Anaemia
European Society for Blood and Marrow Transplantation 205
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07297550
What this trial is testing

Safety and Efficacy of the JAK1 Inhibitor Combined With Intensive Immunosuppressive Therapy in Severe Aplastic Anemia

Who this might be right for
Severe Aplastic AnemiaRefractory Aplastic AnemiaNewly Diagnosed Aplastic Anemia
Institute of Hematology & Blood Diseases Hospital, China 42
Early research (Phase 1)UnknownNCT03836690
What this trial is testing

Transfer of Effector Memory T Cells (Tem) Following Allogeneic Stem Cell Transplantation

Who this might be right for
LymphomaLeukemiaMyeloma+4 more
University College, London 18
Large-scale testing (Phase 3)Active Not RecruitingNCT05600426
What this trial is testing

A Trial Comparing Unrelated Donor BMT With IST for Pediatric and Young Adult Patients With Severe Aplastic Anemia (TransIT, BMT CTN 2202)

Who this might be right for
Severe Aplastic Anemia
Boston Children's Hospital 53
Testing effectiveness (Phase 2)UnknownNCT01472055
What this trial is testing

Pharmacokinetic Study of Fludarabine in Pediatric Hematopoietic Stem Cell Transplantation

Who this might be right for
Acute LeukemiaChronic LeukemiaSevere Aplastic Anemia
Seoul National University Hospital 46
Not applicableAvailableNCT01881334
What this trial is testing

Expanded Access to T-cell Depleted Haplo-Identical Stem Cells for Patients Receiving Haplo-Identical and Unrelated Cord Blood Transplants

Who this might be right for
Hematologic MalignanciesInborn Errors of Metabolism DisordersImmune Deficiencies
Joanne Kurtzberg, MD
Not applicableLooking for participantsNCT05012111
What this trial is testing

Natural History of Acquired and Inherited Bone Marrow Failure Syndromes

Who this might be right for
Severe Aplastic AnemiaTelomere Biology DisordersInherited Bone Marrow Failure Syndromes
National Heart, Lung, and Blood Institute (NHLBI) 1,000
Testing effectiveness (Phase 2)UnknownNCT05720234
What this trial is testing

Avatrombopag Combined With IST as First-line Treatment for SAA

Who this might be right for
Severe Aplastic Anemia
Institute of Hematology & Blood Diseases Hospital, China 53
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07001254
What this trial is testing

UI-Romi-02; Romiplostim Added to Standard of Care for Treatment Naive and Relapsed or Refractory Severe Aplastic Anemia

Who this might be right for
Aplastic Anemia
Anjali Sharathkumar 15
Testing effectiveness (Phase 2)Study completedNCT02797977
What this trial is testing

A Phase 1/2 Trial SRA737 in Combination With Gemcitabine and Cisplatin or Gemcitabine Alone in Advanced Cancer Subjects

Who this might be right for
Advanced Solid Tumors
Sierra Oncology LLC - a GSK company 153
Not applicableEnded earlyNCT02179359
What this trial is testing

Hematopoietic Stem Cell Transplant for High Risk Hemoglobinopathies

Who this might be right for
Sickle Cell DiseaseTransfusion Dependent Alpha- or Beta- ThalassemiaDiamond Blackfan Anemia+5 more
Masonic Cancer Center, University of Minnesota 38
Testing effectiveness (Phase 2)Looking for participantsNCT04304820
What this trial is testing

Early Initiation of Oral Therapy With Cyclosporine and Eltrombopag for Treatment Naive Severe Aplastic Anemia (SAA)

Who this might be right for
Severe Aplastic Anemia
National Heart, Lung, and Blood Institute (NHLBI) 80
Not applicableStudy completedNCT00053157
What this trial is testing

Sargramostim in Reducing Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplantation for Hematologic Cancer or Aplastic Anemia

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+3 more
Roswell Park Cancer Institute 10
Early research (Phase 1)Ended earlyNCT00354419
What this trial is testing

Cyclophosphamide, Antithymocyte Globulin, and Total-Body Irradiation in Treating Patients With Severe Aplastic Anemia Undergoing Umbilical Cord Blood Transplant

Who this might be right for
Aplastic Anemia
Fred Hutchinson Cancer Center 30
Next Page